In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
An illustration
Feature
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.
Pictured: Milind Rajadhyaksha, Snehal Patel & Ricardo Toledo-Crow
Out of the Lab and into the World: The Endoscopic Laser Scalpel

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.
Pictured: Craig Thompson
Perspective
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
Pictured: Scott W. Lowe
Biologist Scott Lowe Joins Memorial Sloan Kettering

Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center.
Pictured: Douglas Levine
Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
MSK doctors
Memorial Sloan Kettering Researchers Discover How Gene Mutation Contributes to Leukemia

A study led by researchers at Memorial Sloan Kettering and New York University has shown that <i>TET2</i> loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.
Charles Sawyers
Charles Sawyers Receives Korsmeyer Award

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation.
Brett Carver
Memorial Sloan Kettering Researchers Discover How Prostate Cancer Disease Pathways Regulate Each Other

Memorial Sloan Kettering researchers have discovered that the AR and PI3K disease pathways regulate each other through reciprocal negative feedback.
Hands on keyboard
New Tool to Predict Breast Cancer Metastasis

Memorial Sloan Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman's disease will become life threatening.